| Item Type | Name |
|
Academic Article
|
Burden of liver disease in the United States: summary of a workshop.
|
|
Academic Article
|
Association between hepatitis C infection and other infectious diseases: a case for targeted screening?
|
|
Academic Article
|
Hepatocellular carcinoma: recent trends in the United States.
|
|
Academic Article
|
Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States.
|
|
Academic Article
|
Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans.
|
|
Academic Article
|
Psychiatric disorders among veterans with hepatitis C infection.
|
|
Academic Article
|
Oral contraception and the risk of hepatocellular carcinoma.
|
|
Academic Article
|
Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C.
|
|
Academic Article
|
The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
|
|
Academic Article
|
Statin therapy and serum transaminases among a cohort of HCV-infected veterans.
|
|
Academic Article
|
The dawn of a new era: transforming our domestic response to hepatitis B & C.
|
|
Academic Article
|
Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection.
|
|
Academic Article
|
Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study.
|
|
Academic Article
|
Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection.
|
|
Academic Article
|
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
|
|
Academic Article
|
The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
|
|
Academic Article
|
Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era.
|
|
Academic Article
|
Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment".
|
|
Academic Article
|
Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy.
|
|
Academic Article
|
The performance of process measures in hepatitis C.
|
|
Academic Article
|
Process of care for hepatitis C infection is linked to treatment outcome and virologic response.
|
|
Academic Article
|
a-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.
|
|
Academic Article
|
Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.
|
|
Academic Article
|
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
|
|
Academic Article
|
Effect of human immunodeficiency virus and antiretrovirals on outcomes of hepatitis C: a systematic review from an epidemiologic perspective.
|
|
Academic Article
|
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
|
|
Academic Article
|
Hepatitis C infection: dying with or from the infection?
|
|
Academic Article
|
Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease.
|
|
Academic Article
|
Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection.
|
|
Academic Article
|
Level of a-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma.
|
|
Academic Article
|
Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients.
|
|
Academic Article
|
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases.
|
|
Academic Article
|
Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males.
|
|
Academic Article
|
Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors.
|
|
Academic Article
|
Finasteride and methadone use and risk of advanced hepatitis C related liver disease.
|
|
Academic Article
|
Racial differences in the association between adiposity measures and the risk of hepatitis C-related liver disease.
|
|
Academic Article
|
Surveillance for hepatocellular carcinoma: long way to achieve effectiveness.
|
|
Academic Article
|
Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients.
|
|
Academic Article
|
CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages.
|
|
Academic Article
|
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.
|
|
Academic Article
|
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.
|
|
Academic Article
|
Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
|
|
Academic Article
|
Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis.
|
|
Academic Article
|
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
|
|
Academic Article
|
Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.
|
|
Academic Article
|
Overview of the viral hepatitis problem.
|
|
Academic Article
|
The changing pattern of epidemiology in hepatocellular carcinoma.
|
|
Academic Article
|
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.
|
|
Academic Article
|
Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
|
|
Academic Article
|
Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.
|
|
Academic Article
|
Hepatocellular carcinoma.
|
|
Academic Article
|
Epidemiology of viral hepatitis and hepatocellular carcinoma.
|
|
Academic Article
|
CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages.
|
|
Concept
|
Hepatitis B Surface Antigens
|
|
Concept
|
Hepatitis B virus
|
|
Concept
|
Viral Hepatitis Vaccines
|
|
Concept
|
Hepatitis, Autoimmune
|
|
Concept
|
Hepatitis B
|
|
Concept
|
Hepatitis, Viral, Human
|
|
Concept
|
Hepatitis C
|
|
Concept
|
Hepatitis C, Chronic
|
|
Concept
|
Hepatitis A Vaccines
|
|
Concept
|
Hepatitis
|
|
Concept
|
Hepatitis B Antibodies
|
|
Concept
|
Hepatitis B e Antigens
|
|
Concept
|
Hepatitis B, Chronic
|
|
Concept
|
Hepatitis A Antibodies
|
|
Concept
|
Hepatitis B Vaccines
|
|
Academic Article
|
Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
|
|
Academic Article
|
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
|
|
Academic Article
|
Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey.
|
|
Academic Article
|
WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients.
|
|
Academic Article
|
Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection.
|
|
Academic Article
|
Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities.
|
|
Academic Article
|
A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
|
|
Academic Article
|
HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.
|
|
Academic Article
|
Hepatitis C virus treatment: the unyielding chasm between efficacy and effectiveness.
|
|
Academic Article
|
Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
|
|
Academic Article
|
Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
|
|
Academic Article
|
Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.
|
|
Academic Article
|
Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection.
|
|
Academic Article
|
Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.
|
|
Academic Article
|
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.
|
|
Academic Article
|
The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.
|
|
Academic Article
|
Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.
|
|
Academic Article
|
Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus.
|
|
Academic Article
|
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
|
|
Academic Article
|
Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.
|
|
Academic Article
|
?Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study.
|
|
Academic Article
|
Global epidemiology and burden of HCV infection and HCV-related disease.
|
|
Academic Article
|
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
|
|
Academic Article
|
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.
|
|
Academic Article
|
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.
|
|
Academic Article
|
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop.
|
|
Academic Article
|
A research agenda for curing chronic hepatitis B virus infection.
|
|
Academic Article
|
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir.
|
|
Academic Article
|
Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
|
|
Academic Article
|
Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
|
|
Academic Article
|
Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection.
|
|
Academic Article
|
Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection.
|
|
Academic Article
|
Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis.
|
|
Academic Article
|
Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey.
|
|
Academic Article
|
Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285].
|
|
Academic Article
|
Epidemiology and Management of Hepatocellular Carcinoma.
|
|
Grant
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
|
Grant
|
Epidemiology and Outcomes of Digestive and Liver Diseases: A Mentoring Program
|
|
Grant
|
Surveillance for Hepatocellular Carcinoma among HCV-infected Veterans
|
|
Academic Article
|
The Epidemiology of Hepatocellular Carcinoma in the USA.
|
|
Academic Article
|
The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection.
|
|
Academic Article
|
Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
|
|
Academic Article
|
Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents.
|
|
Academic Article
|
Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population.
|
|
Academic Article
|
Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort.
|
|
Academic Article
|
Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection.
|
|
Academic Article
|
Epidemiology of Hepatocellular Carcinoma.
|
|
Academic Article
|
Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review.
|
|
Academic Article
|
Low Yield of Hepatitis C Infection in an Outreach Screening Program in Harris County, Texas.
|
|
Academic Article
|
Persistent Challenges in the Hepatitis C Virus Care Continuum for Patients in a Central Texas Public Health System.
|
|
Academic Article
|
Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States.
|
|
Academic Article
|
Risk factors for HCC in contemporary cohorts of patients with cirrhosis.
|
|
Academic Article
|
The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus.
|
|
Academic Article
|
Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population.
|
|
Academic Article
|
Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis.
|
|
Academic Article
|
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.
|
|
Academic Article
|
Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
|
|
Academic Article
|
Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study.
|